Skip to content
Screener

Interest Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$700K+133%
Labcorp Holdings logo
Labcorp HoldingsLH
$5.6M+229%
NeoGenomics logo
NeoGenomicsNEO
$1.21M-46.4%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$3.9M+257%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.17M+7.2%
Agilent Technologies logo
Agilent TechnologiesA
$13M-7.1%

Segments

By segment

See full
Laboratory Services$8.65M+7.9%
Therapeutic Development$0

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Total operating expenses56,11248,141
Operating loss(34,622)(19,795)
Other income (expenses)
Interest income8,6518,018
Interest expense(17)(14)
Other income, net1068
Total other income, net8,6448,072
Loss before income taxes(25,978)(11,723)

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s interest income?
Fulgent Genetics, Inc. (FLGT) reported interest income of $8.65M in Q1 2026.
How has Fulgent Genetics, Inc.'s interest income changed year-over-year?
Fulgent Genetics, Inc.'s interest income increased by 7.9% year-over-year, from $8.02M to $8.65M.
What is the long-term trend for Fulgent Genetics, Inc.'s interest income?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s interest income has grown at a 117.5% compound annual growth rate (CAGR), from $1.38M to $30.92M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Fulgent Genetics, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude